Form 4: Clover Health CEO's Tax-Related Stock Sale

Clover Health's CEO of Home Care, Brady Priest, disposed of 25,081 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Summary

• Brady Patrick Priest, CEO of Home Care at Clover Health Investments, Corp., reported a disposition of shares.
• On July 31, 2025, 25,081 shares of Class A Common Stock were disposed of at a price of $2.89 per share.
• This disposition was due to shares being automatically withheld to cover tax obligations upon the vesting of restricted stock units (RSUs).
• The vesting on July 31, 2025, represented 12.5% of the original time-based RSUs granted to Mr. Priest on October 31, 2023.
• Following this transaction, Mr. Priest beneficially owns 2,471,357 shares of Class A Common Stock.
• The remaining RSUs are scheduled for a final vesting on October 31, 2025, contingent on his continued service.

Sentiment

Score: 6

Explanation: The filing reports a routine, non-discretionary disposition of shares by an executive to cover tax obligations upon RSU vesting. This is a standard compensation event and the executive retains a significant equity stake, indicating continued alignment.

Positives

• Vesting of restricted stock units indicates the fulfillment of compensation agreements, aligning executive incentives with company performance.
• The CEO of Home Care retains a substantial beneficial ownership of 2,471,357 shares, demonstrating continued alignment with shareholder interests.

Negatives

• A disposition of 25,081 shares by a key executive, even for tax purposes, reduces their direct equity stake in the company.

Risks

• The final vesting of remaining restricted stock units on October 31, 2025, is subject to the Reporting Person's continued service, posing a potential retention risk for a key executive.

Future Outlook

Remaining restricted stock units are scheduled for a final vesting on October 31, 2025, contingent on the CEO of Home Care's continued service.

Industry Context

This insider transaction is a routine compensation event for an executive in the healthcare technology sector, reflecting standard equity compensation practices within the industry.

Related Party Transactions

• The disposition of shares was an automatic withholding by the issuer (Clover Health Investments, Corp.) to cover the reporting person's tax obligations related to RSU vesting.

Stakeholder Impact

• Shareholders: Minor dilution from RSU vesting (already accounted for in compensation plans) and a slight reduction in insider ownership, though the disposition is non-discretionary.
• Employees: Reflects standard executive compensation practices, potentially signaling stability in compensation structures.

Next Steps

• Final vesting of remaining restricted stock units for Brady Priest on October 31, 2025, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary disposition of shares by an executive to cover tax obligations upon the vesting of restricted stock units. It does not indicate any change in the company's operational performance, strategic direction, or the executive's confidence in the company. The executive retains a substantial beneficial ownership, which aligns their interests with shareholders. Therefore, this specific filing does not provide new information that would warrant a change in investment recommendation; a 'hold' stance is maintained based on the absence of new material information impacting the company's fundamentals.

Keywords

Clover Health, CLOV, SEC Form 4, Insider Trading, Stock Sale, RSU Vesting, Executive Compensation, Brady Priest, Healthcare Technology, Medicare Advantage